Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

8.870
+0.0650.74%
Volume:26.34M
Turnover:233.42M
Market Cap:102.20B
PE:22.32
High:8.945
Open:8.625
Low:8.625
Close:8.805
52wk High:10.720
52wk Low:6.387
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:0.51
T/O Rate:0.23%
Dividend:0.34
Dividend Rate:3.80%
EPS(LYR):0.397
ROE:20.90%
ROA:10.70%
PB:2.32
PE(LYR):22.32
PS:2.79

Loading ...

CSPC Pharmaceutical Group - Interim Dividend of HK18 Cents Per Share for 2026

THOMSON REUTERS
·
Aug 20

Movement Alert|CSPC PHARMA Rises 12.49% in Regular Trading, Interim Results Day Coupled with Multiple Positive Catalysts

Market Focus
·
Aug 20

CSPC Launches Phase Ib/II Trial of Novel PD-1/IL-15 Fusion Protein SYS6090 for Liver Cancer in China

Bulletin Express
·
Aug 19

CSPC Pharmaceutical Group Stock Sheds 1.3% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 19

Does FDA-Backed Mpox mRNA Trial and AstraZeneca Tie-Up Recast the Bull Case For CSPC (SEHK:1093)?

Simply Wall St.
·
Aug 19

CSPC Pharma Says NMPA Accepts NDA for KN026 and Hb1801 for Advanced Breast Cancer

Reuters
·
Aug 18

CSPC Pharma Unit's Breast Cancer Drug Application Granted Priority Review in China

MT Newswires Live
·
Aug 18

Alphamab Oncology Says China NMPA Accepts Anbenitamab NDA for First-Line HER2+ Advanced Breast Cancer

Reuters
·
Aug 18

CSPC Pharmaceutical - Kn026 and Hb1801 Combination Previously Granted Breakthrough Therapy Designation by Nmpa

THOMSON REUTERS
·
Aug 18

CSPC Pharmaceutical - Nda Indication: First-Line Treatment of Unresectable or Metastatic Her2-Positive Breast Cancer

THOMSON REUTERS
·
Aug 18

CSPC Innovation Posts RMB 1.26 Billion H1 Net Profit on RMB 3.24 Billion Revenue

Reuters
·
Aug 17

CSPC Innovation Pharmaceutical H1 Net Profit 1.3 Billion Yuan

Reuters
·
Aug 17

Movement Alert|CSPC PHARMA Rises 3.22% in Regular Trading, Innovative Pharma Sector Strengthens as AstraZeneca Payments Confirmed

Market Focus
·
Aug 17

CSPC Pharmaceutical Group Stock Rallies 2.0% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 13

Earning Preview: CSPC PHARMA Q2 revenue expected to increase by 25.43%, institutional views are bullish

Earnings Agent
·
Aug 13

Movement Alert|CSPC PHARMA Rises 3.57% in Regular Trading, AstraZeneca siRNA Collaboration $30 Million Upfront Payment Received

Market Focus
·
Aug 13

CSPC Pharmaceutical Changes Trustee for 2018 Share Award Scheme to BOCI Trustee Hong Kong

Reuters
·
Aug 12

CSPC Pharmaceutical Group Announces Change in Trustee for 2018 Share Award Scheme

Stock News
·
Aug 12

CSPC Pharmaceutical Receives USD 30 Million Upfront Payment from AstraZeneca Under siRNA Pact

Reuters
·
Aug 12

CSPC Pharmaceutical - Receives US$30 Mln Upfront Payment from AstraZeneca on Aug 12 2026 Under Collaboration Agreement

THOMSON REUTERS
·
Aug 12